Home Based Clinical Management of Interstitial Lung Disease in Systemic Rheumatic Diseases

This study is testing a home-based monitoring and management program for people who have lung scarring (interstitial lung disease, or ILD) caused by a rheumatic disease such as rheumatoid arthritis, scleroderma, or myositis. The goal is to see whether managing ILD from home is as good as or better than standard clinic-based care. **You may be eligible if...** - You have a systemic rheumatic disease (e.g., systemic sclerosis, rheumatoid arthritis, inflammatory myopathies, mixed connective tissue disease, or Sjögren's disease) - You have been diagnosed with ILD on a CT scan for at least 1 year - You have been on stable treatment for the past 6 months - You have internet access and can use a smartphone or tablet - You are able to understand and complete questionnaires **You may NOT be eligible if...** - Your ILD diagnosis is less than 1 year old - Your treatment has changed in the past 6 months - You cannot use digital devices or access the internet Talk to your doctor to see if this trial is right for you.